237 related articles for article (PubMed ID: 8016872)
21. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
22. Protection of corneal allografts by CTLA4-Ig.
Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
[TBL] [Abstract][Full Text] [Related]
24. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
25. [CTLA4-Ig prevents corneal allograft rejection in mice].
Shi WY; Xie LX
Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
[TBL] [Abstract][Full Text] [Related]
26. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
27. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
[TBL] [Abstract][Full Text] [Related]
28. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
Bolling SF; Lin H; Wei RQ; Linsley P; Turka LA
J Surg Res; 1994 Jul; 57(1):60-4. PubMed ID: 8041150
[TBL] [Abstract][Full Text] [Related]
29. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
30. Tolerance induction by soluble CTLA4 in a mouse skin transplant model.
Tepper MA; Linsley PS; Tritschler D; Esselstyn JM
Transplant Proc; 1994 Dec; 26(6):3151-4. PubMed ID: 7998099
[No Abstract] [Full Text] [Related]
31. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
32. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
33. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
Baliga P; Chavin KD; Qin L; Woodward J; Lin J; Linsley PS; Bromberg JS
Transplantation; 1994 Nov; 58(10):1082-90. PubMed ID: 7526493
[TBL] [Abstract][Full Text] [Related]
34. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
Lakkis FG; Konieczny BT; Saleem S; Baddoura FK; Linsley PS; Alexander DZ; Lowry RP; Pearson TC; Larsen CP
J Immunol; 1997 Mar; 158(5):2443-8. PubMed ID: 9036995
[TBL] [Abstract][Full Text] [Related]
35. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
36. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
37. AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Int; 2004 Jan; 17(1):15-21. PubMed ID: 12942167
[TBL] [Abstract][Full Text] [Related]
38. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
Israël-Assayag E; Fournier M; Cormier Y
J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
[TBL] [Abstract][Full Text] [Related]
39. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
Lin H; Bolling SF; Linsley PS; Wei RQ; Gordon D; Thompson CB; Turka LA
J Exp Med; 1993 Nov; 178(5):1801-6. PubMed ID: 8228826
[TBL] [Abstract][Full Text] [Related]
40. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
Lane P; Haller C; McConnell F
Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
